Daniel Stover, Medical Oncologist and Computational Biologist at Ohio State University Comprehensive Cancer Center, shared on LinkedIn:
“Lobular breast cancer will benefit from exciting young minds like Arya Roy driving forward progress in new areas – like digital pathology and AI.
The Lobular Breast Cancer Alliance is a special organization and look forward to continue to support their mission as Dr. Roy adds to their incredible group of scientific advisors.
Congratulations to both LBCA and Dr. Roy on this great partnership!”
Quoting Lobular Breast Cancer Alliance:
“LBCA is pleased to welcome Dr. Arya Roy as the newest member of our Scientific Advisory Board!
Dr. Roy is an Assistant Professor in the Division of Medical Oncology, Department of Internal Medicine, at The Ohio State University and a medical oncologist at The James Cancer Hospital and Solove Research Institute. She is part of the team behind the James’ ILC-focused program and has already contributed to LBCA’s development of ILC educational materials for patients and clinicians.
Dr. Roy joins LBCA’s Scientific Advisory Board following the departure of her colleague Dr. Daniel Stover. LBCA extends its sincere appreciation to Dr. Stover for his expertise and service to the SAB and his efforts to advance the James Cancer Hospital’s focus on ILC research.
We are grateful for Dr. Stover’s contributions and pleased to welcome Dr. Roy to the Scientific Advisory Board!
Learn more about LBCA’s Scientific Advisory Board.”
Other articles from Daniel Stover on OncoDaily.